Benign prostatic hyperplasia (BPH) is a disease that affects over 30 million men in the USA and a similar or higher number in Europe. It particularly affects men over the age of 50, which is the fastest growing age-group in western countries.
In the past five years there have been tremendous advances in the treatment of BPH, particularly in medical and minimally invasive therapies. This timely book provides in-depth coverage of the whole area of BPH, and particularly focuses on new advances in treatment.
• The definitive guide to the management of this increasingly prevalent disease.
• Covers the latest medical treatments, including prostate-selective alpha blockers.
• Discusses minimally invasive therapies.
• Advises on when to use traditional surgery.
• Covers new data on TUNA, microwave and interstitial laser treatments.
• Contains updated clinical practice guidelines in the evaluation role of PSA, the role of the primary care physician, and socio-economic, trends in the USA and Europe.
Illustrated throughout in full color, with state-of-the-art graphics designed especially for the book, and organized in a user-friendly format, Benign Prostatic Hyperplasia will be an essential addition to the library of all urologists. It will also provide an invaluable resource to the urology trainee, and to the interested primary care physician.